99 related articles for article (PubMed ID: 3983584)
21. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y
Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736
[TBL] [Abstract][Full Text] [Related]
22. [Hypercalcemia associated with tumors in children. 20 cases].
Leblanc A; Hartmann O; Pons G; Caillaud JM; Couanet D; Lenoir G; Lemerle J
Arch Fr Pediatr; 1984 Oct; 41(8):551-5. PubMed ID: 6508484
[TBL] [Abstract][Full Text] [Related]
23. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
24. Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
Leonard JP; Coleman M; Ketas J; Ashe M; Fiore JM; Furman RR; Niesvizky R; Shore T; Chadburn A; Horne H; Kovacs J; Ding CL; Wegener WA; Horak ID; Goldenberg DM
J Clin Oncol; 2005 Aug; 23(22):5044-51. PubMed ID: 15955901
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
[TBL] [Abstract][Full Text] [Related]
26. Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas.
Borchmann P; Morschhauser F; Parry A; Schnell R; Harousseau JL; Gisselbrecht C; Rudolph C; Wilhelm M; Günther H; Pfreundschuh DM; Camboni G; Engert A
Haematologica; 2003 Aug; 88(8):888-94. PubMed ID: 12935976
[TBL] [Abstract][Full Text] [Related]
27. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
28. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
29. [Malignant non-Hodgkin's lymphoma with visual disorders and nephrotic syndrome].
Flury W; Wegmüller E; Zeltner T; Niesel P
Schweiz Med Wochenschr; 1982 Mar; 112(13):448-53. PubMed ID: 7071567
[TBL] [Abstract][Full Text] [Related]
30. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma.
Rothe A; Schulz H; Elter T; Engert A; Reiser M
Haematologica; 2004 Jul; 89(7):875-6. PubMed ID: 15257947
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
Addeo R; Caraglia M; Costanzo R; Faiola V; Montella L; Abbruzzese A; Del Prete S
Oncol Rep; 2004 Jul; 12(1):135-40. PubMed ID: 15201974
[TBL] [Abstract][Full Text] [Related]
32. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy of non-hodgkin's lymphomas (author's transl)].
Fereberger W; Neubauer M
Acta Med Austriaca; 1981; 8(1):1-6. PubMed ID: 7234308
[TBL] [Abstract][Full Text] [Related]
34. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
36. [Humoral hypercalcemia revealing a malignant non hodgkin lymphoma].
Amezyane T; Lecoules S; Bordier L; Blade JS; Desramé J; Bechade D; Coutant G; Algayres JP
Ann Endocrinol (Paris); 2008 Feb; 69(1):58-62. PubMed ID: 18164274
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review.
Shallis RM; Rome RS; Reagan JL
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e123-e129. PubMed ID: 29361495
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma.
Jacobs RH; Larson RA; LeBeau M; Kluskens LF; Vardiman JW; Rowley JD; Golomb HM
N Engl J Med; 1984 Jan; 310(4):263-4. PubMed ID: 6318111
[No Abstract] [Full Text] [Related]
39. Non-Hodgkin's lymphoma and 1,25(OH)2D-related hypercalcaemia.
Craanen ME; van Beugen L; Blok P
Neth J Med; 1990 Oct; 37(3-4):129-31. PubMed ID: 2250755
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases.
Leblanc A; Caillaud JM; Hartmann O; Kalifa C; Flamant F; Patte C; Tournade MF; Lemerle J
Cancer; 1984 Nov; 54(10):2132-6. PubMed ID: 6091859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
